PLx Pharma Inc.
PLXP · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $189,440 | $53,627 | $38,964 | $13,362 |
| - Cash | $69,392 | $22,449 | $14,001 | $14,250 |
| + Debt | $0 | $622 | $4,280 | $7,190 |
| Enterprise Value | $120,048 | $31,800 | $29,243 | $6,302 |
| Revenue | $8,208 | $30 | $565 | $753 |
| % Growth | 26,873.4% | -94.6% | -24.9% | – |
| Gross Profit | $3,403 | $30 | $565 | $753 |
| % Margin | 41.5% | 100% | 100% | 100% |
| EBITDA | -$35,241 | -$14,487 | -$13,797 | $2,243 |
| % Margin | -429.3% | -47,607.9% | -2,440% | 297.9% |
| Net Income | -$51,460 | -$15,103 | -$21,339 | $896 |
| % Margin | -626.9% | -49,631.9% | -3,773.7% | 119% |
| EPS Diluted | -2.18 | -1.55 | -2.39 | 0.1 |
| % Growth | -40.6% | 35.1% | -2,490% | – |
| Operating Cash Flow | -$32,118 | -$12,244 | -$12,659 | -$9,499 |
| Capital Expenditures | $0 | -$102 | -$242 | -$655 |
| Free Cash Flow | -$32,118 | -$12,346 | -$12,901 | -$10,154 |